Ads
related to: urinary problems after prostate cancer treatment abiraterone- Educational Brochures
Get Resources Now For
APC Treatment
- Patient Support Program
Support to Help Your Patients
Get Started and Stay on Track
- Safety & Efficacy Video
Watch A Video To Learn
More About This Treatment Option.
- Coverage for Rx Treatment
Learn About Coverage
In Your Area
- Educational Brochures
Search results
Results From The WOW.Com Content Network
Abiraterone acetate is used in combination with prednisone, a corticosteroid, as a treatment for mCRPC (previously called hormone-resistant or hormone-refractory prostate cancer). [2] [6] [5] [4] This is a form of prostate cancer that is not responding to first-line androgen deprivation therapy or treatment with androgen receptor antagonists.
Niraparib/abiraterone acetate, sold under the brand name Akeega, is a fixed-dose combination anti-cancer medication used for the treatment of prostate cancer. [2] It contains niraparib , a poly (ADP-ribose) polymerase (PARP) inhibitor (antineoplastic agent), and abiraterone acetate , a CYP17 inhibitor (hormone antagonist).
Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.
A common and usually benign complaint, it may be a symptom of urethral diverticulum, prostatitis and other medical problems. [1] Some men who experience dribbling, especially after prostate cancer surgery, will choose to wear incontinence pads to stay dry. Also known as guards for men, these incontinence pads conform to the male body.
It is responsible for producing fluid that helps with sperm movement. Due to its location within the body, when diseased, it can affect the reproductive and urinary systems. [3] Prostate diseases, such as prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer all affect the functioning of this gland. [9] [10]
The prostate is a gland that is found under the rectum and below the bladder in the male reproductive system. [5] Five randomized controlled trials were conducted to determine whether prostate cancer screening reduces mortality associated with prostate cancer where 341,342 participants within the age range of 45–80 years were included in the ...